The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles JACC: Heart Failure Year : 2021

The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials

Silvia Oghina
  • Function : Author
Wulfran Bougouin
  • Function : Author
Mélanie Bézard
  • Function : Author
Michel Komajda
  • Function : Author
Alain Cohen-Solal
  • Function : Author
Alexandre Mebazaa
  • Function : Author
Thibaud Damy
  • Function : Author
Diane Bodez
  • Function : Author

Dates and versions

hal-04395397 , version 1 (15-01-2024)

Identifiers

Cite

Silvia Oghina, Wulfran Bougouin, Mélanie Bézard, Mounira Kharoubi, Michel Komajda, et al.. The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials. JACC: Heart Failure, 2021, 9 (3), pp.169-178. ⟨10.1016/j.jchf.2020.12.005⟩. ⟨hal-04395397⟩

Collections

IMRB UPEC
4 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More